| |
| |
|
| Insider
Information: |
Thompson Tommy G |
| Relationship: |
Director |
| City: |
Saint Louis |
| State: |
MO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
2,385,169 |
|
|
Indirect Shares
|
5,118,253 |
|
|
| Direct
Value |
$23,806,633 |
|
|
|
Indirect Value
|
$16,137,188 |
|
|
| Total
Shares |
7,503,422 |
|
|
| Total
Value |
$39,943,821 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
3
|
|
Stock
price went up :
|
1
|
3
|
| Stock
price went down : |
4
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
 -26.9%
|
 104.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Centene Corp |
CNC |
Director |
2021-12-31 |
227,334 |
2021-12-31 |
160,896 |
Premium* |
|
|
CR Bard Inc |
BCR |
Director |
2017-12-29 |
0 |
2005-10-03 |
0 |
Premium* |
|
|
Pure Bioscience |
PURE |
Director |
2009-07-01 |
589,537 |
2007-05-23 |
0 |
Premium* |
|
|
United Therapeutics Corp |
UTHR |
|
2024-03-11 |
8,480 |
2024-03-08 |
14,000 |
Premium* |
|
|
Careview Communications Inc |
CRVW |
Director |
2012-12-26 |
1,325,222 |
2013-04-01 |
4,845,424 |
Premium* |
|
|
Plus Therapeutics Inc |
PSTV |
Director |
2015-05-08 |
103,986 |
2015-09-03 |
83,600 |
Premium* |
|
|
Therapeuticsmd Inc |
TXMD |
Director |
2022-08-18 |
5,954 |
2022-08-18 |
14,333 |
Premium* |
|
|
Physicians Realty Trust |
DOC |
Director |
2024-03-01 |
0 |
2024-03-01 |
0 |
Premium* |
|
|
Vyant Bio Ord Shs |
VYNT |
Director |
2013-10-10 |
2,500 |
2013-10-10 |
0 |
Premium* |
|
|
Healthpeak Properties |
PEAK |
Director |
2024-04-26 |
122,156 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
284 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UTHR |
United Therapeutics Corp |
|
– • – |
2023-03-28 |
4 |
D |
$246.04 |
$615,100 |
D/D |
(2,500) |
7,600 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2023-03-03 |
4 |
D |
$248.69 |
$621,725 |
D/D |
(2,500) |
7,600 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Director |
• • – |
2021-03-10 |
4 |
OE |
$54.77 |
$676,410 |
D/D |
12,350 |
17,190 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Director |
• • – |
2015-09-29 |
4 |
S |
$139.19 |
$695,935 |
D/D |
(5,000) |
0 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Director |
• • – |
2019-03-18 |
4 |
OE |
$52.65 |
$900,315 |
D/D |
17,100 |
20,070 |
0 |
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2015-03-13 |
4 |
AS |
$65.36 |
$1,045,760 |
D/D |
(16,000) |
170,307 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Director |
• • – |
2015-02-27 |
4 |
S |
$152.73 |
$1,152,238 |
D/D |
(7,500) |
0 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2024-03-11 |
4 |
D |
$249.51 |
$1,247,550 |
D/D |
(5,000) |
8,480 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Director |
• • – |
2021-03-10 |
4 |
D |
$159.68 |
$1,972,048 |
D/D |
(12,350) |
4,840 |
0 |
- |
|
284 Records found
|
|
Page 12 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
